<DOC>
	<DOCNO>NCT01563978</DOCNO>
	<brief_summary>The purpose study evaluate effect fostamatinib compare placebo ambulatory blood pressure patient active rheumatoid arthritis take disease-modifying anti-rheumatic drug ( DMARD ) . The study last 57 day .</brief_summary>
	<brief_title>Study Effect Fostamatinib Twice Daily Blood Pressure Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description>OSKIRA-ABPM : A Multi-Centre , Randomised , Double-Blind , Placebo-Controlled , Parallel Group Study Effect Fostamatinib 100 mg Twice Daily 24-hour Ambulatory Blood Pressure Patients Rheumatoid Arthritis</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Male female patient age 18 diagnosed rheumatoid arthritis age 16 Active rheumatoid arthritis define : ≥4 swollen joint ≥4 tender/painful joint ( 28 joint count ) either erythrocyte sedimentation rate ≥28 mm/h , Creactive protein ≥10 mg/L . Currently take one follow diseasemodifying antirheumatic drug : methotrexate , sulfasalazine , hydroxychloroquine chloroquine . Patients without essential hypertension essential hypertension blood pressure control ( &lt; 140/90 mmHg ) antihypertensive medication stable least 4 week prior randomisation . Females pregnant breastfeeding . Certain inflammatory condition ( rheumatoid arthritis ) , connective tissue diseases chronic pain disorder History liver problem require previous investigation Evidence tuberculosis infection Conditions preclude render difficult 24hour ambulatory blood pressure monitoring technique .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>